Found: 1
Select item for more details and to access through your institution.
Fenretinide combines perturbation of signaling kinases, cell–extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cells.
- Published in:
- Carcinogenesis, 2022, v. 43, n. 9, p. 851, doi. 10.1093/carcin/bgac070
- By:
- Publication type:
- Article